- Report
- January 2026
- 378 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 196 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 394 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 277 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 472 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 479 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 283 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 374 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 197 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 367 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 486 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 380 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 291 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 274 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 377 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 383 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 177 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 286 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 282 Pages
Global
From €5217EUR$5,850USD£4,523GBP
- Report
- January 2026
- 384 Pages
Global
From €5217EUR$5,850USD£4,523GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more